Royce & Associates LP Enovis Corp Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

A detailed history of Royce & Associates LP transactions in Enovis Corp stock. As of the latest transaction made, Royce & Associates LP holds 2,403,685 shares of ENOV stock, worth $109 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares

2,403,685

Previous 2,057,368 16.83%

Holding current value

$109 Million

Previous $93 Million 11.28%

% of portfolio

0.98%

Previous 0.91%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$40.57 - $48.1 $14.1 Million - $16.7 Million	346,317 Added 16.83%	2,403,685 $103 Million
Q2 2024 Aug 13, 2024	BUY	$44.56 - $62.43 $20.4 Million - $28.5 Million	457,308 Added 28.58%	2,057,368 $93 Million
Q1 2024 May 13, 2024	BUY	$55.44 - $63.8 $366,181 - $421,399	6,605 Added 0.41%	1,600,060 $99.9 Million
Q4 2023 Feb 12, 2024	BUY	$43.67 - $57.07 $10.5 Million - $13.7 Million	240,480 Added 17.77%	1,593,455 $89.3 Million
Q3 2023 Nov 09, 2023	BUY	$51.65 - $65.54 $12.6 Million - $15.9 Million	243,278 Added 21.92%	1,352,975 $71.3 Million
Q2 2023 Aug 07, 2023	SELL	$52.7 - $64.12 $278,783 - $339,194	-5,290 Reduced 0.47%	1,109,697 $71.2 Million
Q1 2023 May 04, 2023	SELL	$49.5 - $65.92 $100,683 - $134,081	-2,034 Reduced 0.18%	1,114,987 $59.6 Million
Q4 2022 May 23, 2023	BUY	$44.83 - $57.43 $91,184 - $116,812	2,034 Added 0.18%	1,117,021 $59.8 Million
Q4 2022 Feb 13, 2023	BUY	$44.83 - $57.43 $5.73 Million - $7.34 Million	127,794 Added 12.92%	1,117,021 $59.8 Million
Q3 2022 Nov 03, 2022	BUY	$46.07 - $60.1 $16.8 Million - $21.9 Million	363,928 Added 58.2%	989,227 $45.6 Million
Q2 2022 Aug 04, 2022	BUY	$55.0 - $70.47 $34.4 Million - $44.1 Million	625,299 New	625,299 $34.4 Million

Others Institutions Holding ENOV

# of Institutions

310

Shares Held

60.3M

Call Options Held

1.68M

Put Options Held

693K

View Full List

About Enovis CORP

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.45B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

More about ENOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Enovis Corp Transaction History